Successful treatment with tocilizumab in a patient with rapidly progressive interstitial lung disease with positive anti-melanoma differentiation-associated gene-5 antibody

Chin Med J (Engl). 2020 Nov 25;134(8):999-1000. doi: 10.1097/CM9.0000000000001235.
No abstract available

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Autoantibodies
  • Dermatomyositis*
  • Disease Progression
  • Humans
  • Lung Diseases, Interstitial* / drug therapy

Substances

  • Antibodies, Monoclonal, Humanized
  • Autoantibodies
  • tocilizumab